GlaxoSmithKline Pharma reports 18% rise in Q4 net profit

16 Feb 2012 Evaluate

GlaxoSmithKline Pharmaceuticals has reported results for fourth quarter ended December 31, 2011.

The company has posted a rise of 18.18% in its net profit at Rs 136.74 crore for the quarter ended December 31, 2011 as compared to Rs 115.70 crore for the same quarter in the previous year. Total income has increased by 15.35% at Rs 577.60 crore for the quarter under review as compared to Rs 500.72 crore year ago.

GlaxoSmithKline Pharmaceuticals is one oldest pharmaceutical company in India. Internationally it has created many brands such as Ribena, Horlicks, Lucozade, Aquafresh, Sensodyne, Panadol, Tums and Zovirax, among others. It employs 5,000 people and has turnover of more than $1 billion in India.

Glaxosmithkline Phar Share Price

2532.85 -10.25 (-0.40%)
08-Dec-2025 15:52 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1790.05
Dr. Reddys Lab 1272.70
Cipla 1498.90
Zydus Lifesciences 924.35
Lupin 2061.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×